Published in Nephrol Dial Transplant on January 19, 2011
Lead and CKD. Nephrol Dial Transplant (2012) 1.07
Environmental heavy metal exposure and chronic kidney disease in the general population. J Korean Med Sci (2015) 0.96
Early chronic low-level lead exposure produces glomerular hypertrophy in young C57BL/6J mice. Toxicol Lett (2013) 0.79
High prevalence of elevated lead levels in pediatric dialysis patients. Pediatr Nephrol (2012) 0.77
Blood lead level and measured glomerular filtration rate in children with chronic kidney disease. Environ Health Perspect (2013) 0.76
Reply: To PMID 21248295. Nephrol Dial Transplant (2012) 0.75
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med (1999) 82.86
A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41
Prediction of creatinine clearance from serum creatinine. Nephron (1976) 64.02
Prevalence of chronic kidney disease in the United States. JAMA (2007) 38.98
Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis (2008) 15.04
Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem (2007) 13.80
Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. Am J Kidney Dis (2007) 7.86
Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis (2002) 6.52
Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int (2008) 5.90
Environmental lead exposure and progression of chronic renal diseases in patients without diabetes. N Engl J Med (2003) 5.18
Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula? Pediatr Nephrol (2003) 2.70
Serum cystatin C in the United States: the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis (2008) 2.64
A Comparison of GFR estimating formulae based upon s-cystatin C and s-creatinine and a combination of the two. Nephrol Dial Transplant (2007) 2.52
Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin C values in mg/L. Scand J Clin Lab Invest (2004) 2.48
Serum cystatin C as a marker of glomerular filtration rate. Curr Opin Nephrol Hypertens (2006) 2.34
Tubular and glomerular kidney effects in Swedish women with low environmental cadmium exposure. Environ Health Perspect (2005) 2.29
Renal function, cytogenetic measurements, and sexual development in adolescents in relation to environmental pollutants: a feasibility study of biomarkers. Lancet (2001) 2.13
Continued decline in blood lead levels among adults in the United States: the National Health and Nutrition Examination Surveys. Arch Intern Med (2005) 2.08
Blood cadmium and lead and chronic kidney disease in US adults: a joint analysis. Am J Epidemiol (2009) 2.06
Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children--a meta-analysis. Clin Biochem (2007) 2.06
Renal and neurologic effects of cadmium, lead, mercury, and arsenic in children: evidence of early effects and multiple interactions at environmental exposure levels. Environ Health Perspect (2006) 2.02
Lead-related nephrotoxicity: a review of the epidemiologic evidence. Kidney Int (2006) 1.67
A longitudinal study of low-level lead exposure and impairment of renal function. The Normative Aging Study. JAMA (1996) 1.57
Lead, diabetes, hypertension, and renal function: the normative aging study. Environ Health Perspect (2004) 1.45
Mechanisms of lead-induced hypertension and cardiovascular disease. Am J Physiol Heart Circ Physiol (2008) 1.41
Bone lead as a new biologic marker of lead dose: recent findings and implications for public health. Environ Health Perspect (1998) 1.38
Second-hand smoke exposure and blood lead levels in U.S. children. Epidemiology (2003) 1.37
Blood lead level and kidney function in US adolescents: The Third National Health and Nutrition Examination Survey. Arch Intern Med (2010) 1.37
Environmental exposure to lead and progression of chronic renal diseases: a four-year prospective longitudinal study. J Am Soc Nephrol (2004) 1.30
Experimental model of lead nephropathy. I. Continuous high-dose lead administration. Kidney Int (1992) 1.17
Blood lead and cadmium levels and relevant factors among children from an e-waste recycling town in China. Environ Res (2008) 0.98
Blood lead levels in children after phase-out of leaded gasoline in Bombay, India. Sci Total Environ (2005) 0.97
Active and passive smoking and blood lead levels in U.S. adults: data from the Third National Health and Nutrition Examination Survey. Nicotine Tob Res (2005) 0.96
The lead content of currently available new residential paint in several Asian countries. Environ Res (2006) 0.95
Low-level environmental exposure to lead and progressive chronic kidney diseases. Am J Med (2006) 0.92
Performance of creatinine clearance equations on the original Cockcroft-Gault population. Clin Nephrol (2006) 0.90
Creatinine and cystatin C: what are the values? Kidney Int (2009) 0.89
Experimental model of lead nephropathy. III. Continuous low-level lead administration. Arch Environ Health (1993) 0.89
Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes. Kidney Int (2006) 0.87
Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med (2004) 17.79
Body-mass index and mortality in Korean men and women. N Engl J Med (2006) 7.50
A behavioral weight-loss intervention in persons with serious mental illness. N Engl J Med (2013) 5.52
Enough is enough: Stop wasting money on vitamin and mineral supplements. Ann Intern Med (2013) 5.28
Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. JAMA (2004) 4.54
Retracted Expression of concern: Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1. Am J Respir Crit Care Med (2008) 3.93
Arsenic exposure and prevalence of type 2 diabetes in US adults. JAMA (2008) 3.83
Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ (2011) 3.69
Rapid response systems: a systematic review. Crit Care Med (2007) 3.51
Blood lead below 0.48 micromol/L (10 microg/dL) and mortality among US adults. Circulation (2006) 3.47
Random-effects meta-analysis of inconsistent effects: a time for change. Ann Intern Med (2014) 3.30
Lead exposure and cardiovascular disease--a systematic review. Environ Health Perspect (2006) 3.11
Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study. Am J Epidemiol (2005) 3.10
Meta-analysis of randomized educational and behavioral interventions in type 2 diabetes. Diabetes Educ (2003) 3.05
Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. Am J Epidemiol (2005) 2.90
Lead, cadmium, smoking, and increased risk of peripheral arterial disease. Circulation (2004) 2.83
Combined cardiac magnetic resonance imaging and C-reactive protein levels identify a cohort at low risk for defibrillator firings and death. Circ Cardiovasc Imaging (2012) 2.62
Cadmium exposure and incident cardiovascular disease. Epidemiology (2013) 2.55
Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol (2013) 2.50
Roxarsone, inorganic arsenic, and other arsenic species in chicken: a U.S.-based market basket sample. Environ Health Perspect (2013) 2.47
Arsenic exposure and type 2 diabetes: a systematic review of the experimental and epidemiological evidence. Environ Health Perspect (2006) 2.44
Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trials. Am J Clin Nutr (2006) 2.40
Sex-steroid hormones and electrocardiographic QT-interval duration: findings from the third National Health and Nutrition Examination Survey and the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol (2011) 2.38
Secondhand smoke exposure among women and children: evidence from 31 countries. Am J Public Health (2008) 2.37
Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study. Eur Heart J (2011) 2.29
Retracted Expression of concern: Heightened endoplasmic reticulum stress in the lungs of patients with chronic obstructive pulmonary disease: the role of Nrf2-regulated proteasomal activity. Am J Respir Crit Care Med (2009) 2.28
Prospective study of particulate air pollution exposures, subclinical atherosclerosis, and clinical cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis and Air Pollution (MESA Air). Am J Epidemiol (2012) 2.23
Associations of multiple metals with kidney outcomes in lead workers. Occup Environ Med (2012) 2.14
Quality of life after acute respiratory distress syndrome: a meta-analysis. Intensive Care Med (2006) 2.13
Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study. Am J Kidney Dis (2013) 2.09
Blood cadmium and lead and chronic kidney disease in US adults: a joint analysis. Am J Epidemiol (2009) 2.06
Evaluation of the association between arsenic and diabetes: a National Toxicology Program workshop review. Environ Health Perspect (2012) 2.05
Influence of serum selenium concentrations on hypertension: the Lipid Analytic Cologne cross-sectional study. J Hypertens (2012) 2.00
Systolic blood pressure, diastolic blood pressure, and pulse pressure: an evaluation of their joint effect on mortality. Ann Intern Med (2003) 1.98
Efficacy and safety of statin monotherapy in older adults: a meta-analysis. J Gerontol A Biol Sci Med Sci (2007) 1.97
Serum selenium and diabetes in U.S. adults. Diabetes Care (2007) 1.96
Serum ferritin and risk of the metabolic syndrome in U.S. adults. Diabetes Care (2004) 1.90
Impact of energy intake, physical activity, and population-wide weight loss on cardiovascular disease and diabetes mortality in Cuba, 1980-2005. Am J Epidemiol (2007) 1.87
Serum selenium levels and all-cause, cancer, and cardiovascular mortality among US adults. Arch Intern Med (2008) 1.82
Effects of vitamin C supplementation on blood pressure: a meta-analysis of randomized controlled trials. Am J Clin Nutr (2012) 1.79
Cadmium levels in urine and mortality among U.S. adults. Environ Health Perspect (2008) 1.79
Cadmium exposure and hypertension in the 1999-2004 National Health and Nutrition Examination Survey (NHANES). Environ Health Perspect (2008) 1.76
Metals in urine and peripheral arterial disease. Environ Health Perspect (2005) 1.76
Seafood intake and urine concentrations of total arsenic, dimethylarsinate and arsenobetaine in the US population. Environ Res (2010) 1.75
QT-interval duration and mortality rate: results from the Third National Health and Nutrition Examination Survey. Arch Intern Med (2011) 1.73
C-reactive protein and colorectal cancer risk: a systematic review of prospective studies. Int J Cancer (2008) 1.71
Prospective study of serum adiponectin and incident metabolic syndrome: the ARIRANG study. Diabetes Care (2012) 1.71
Adverse events during medical and surgical hospitalizations for persons with schizophrenia. Arch Gen Psychiatry (2006) 1.68
Association between exposure to low to moderate arsenic levels and incident cardiovascular disease. A prospective cohort study. Ann Intern Med (2013) 1.67
Meta-analysis of folic acid supplementation trials on risk of cardiovascular disease and risk interaction with baseline homocysteine levels. Am J Cardiol (2010) 1.64
Urine arsenic concentrations and species excretion patterns in American Indian communities over a 10-year period: the Strong Heart Study. Environ Health Perspect (2009) 1.63
Selenium and coronary heart disease: a meta-analysis. Am J Clin Nutr (2006) 1.62
Electrocardiographic QT interval and mortality: a meta-analysis. Epidemiology (2011) 1.62
Urine arsenic and prevalent albuminuria: evidence from a population-based study. Am J Kidney Dis (2012) 1.59
Confounding of the relation between homocysteine and peripheral arterial disease by lead, cadmium, and renal function. Am J Epidemiol (2006) 1.59
Body mass index and incident ischemic heart disease in South Korean men and women. Am J Epidemiol (2005) 1.57
A prospective study of plasma ferritin level and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol (2007) 1.55
The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. Am J Hypertens (2002) 1.54
Past history of skin infection and risk of surgical site infection after elective surgery. Ann Surg (2013) 1.52
Bone lead levels and blood pressure endpoints: a meta-analysis. Epidemiology (2008) 1.48
Vitamin D supplementation in the age of lost innocence. Ann Intern Med (2010) 1.45
Environmental chemicals and type 2 diabetes: an updated systematic review of the epidemiologic evidence. Curr Diab Rep (2013) 1.44
Arsenic exposure and hypertension: a systematic review. Environ Health Perspect (2011) 1.44
Association of cigarette smoking, alcohol consumption, and physical activity with sex steroid hormone levels in US men. Cancer Causes Control (2009) 1.43
Arsenic in drinking water and lung cancer: a systematic review. Environ Res (2008) 1.43
The efficacy of sirolimus- and paclitaxel-eluting stents: a meta-analysis of randomized controlled trials. Can J Cardiol (2005) 1.42
Arsenic in public water supplies and cardiovascular mortality in Spain. Environ Res (2009) 1.41
Environmental monitoring of secondhand smoke exposure. Tob Control (2012) 1.39
Cruciferous vegetable consumption and lung cancer risk: a systematic review. Cancer Epidemiol Biomarkers Prev (2009) 1.38
Rejoinder: Arsenic exposure and prevalence of type 2 diabetes: updated findings from the National Health Nutrition and Examination Survey, 2003-2006. Epidemiology (2009) 1.38
Cadmium exposure and all-cause and cardiovascular mortality in the U.S. general population. Environ Health Perspect (2012) 1.37
Serum selenium concentrations and diabetes in U.S. adults: National Health and Nutrition Examination Survey (NHANES) 2003-2004. Environ Health Perspect (2009) 1.37
Blood lead level and kidney function in US adolescents: The Third National Health and Nutrition Examination Survey. Arch Intern Med (2010) 1.37
Reduction in cadmium exposure in the United States population, 1988-2008: the contribution of declining smoking rates. Environ Health Perspect (2011) 1.35
Arsenic exposure and cardiovascular disease: an updated systematic review. Curr Atheroscler Rep (2012) 1.32
Secondhand tobacco smoke: a source of lead exposure in US children and adolescents. Am J Public Health (2011) 1.31
Carotenoids and the risk of developing lung cancer: a systematic review. Am J Clin Nutr (2008) 1.31
Prospective observational study of implantable cardioverter-defibrillators in primary prevention of sudden cardiac death: study design and cohort description. J Am Heart Assoc (2013) 1.30
Secondhand tobacco smoke in bars and restaurants in Santiago, Chile: evaluation of partial smoking ban legislation in public places. Tob Control (2010) 1.27
Nrf2-dependent sulfiredoxin-1 expression protects against cigarette smoke-induced oxidative stress in lungs. Free Radic Biol Med (2008) 1.27
Arsenic species and selected metals in human urine: validation of HPLC/ICPMS and ICPMS procedures for a long-term population-based epidemiological study. Anal Methods (2012) 1.27